Letter from the Editor in Chief

DOI: 10.19102/icrm.2019.100303

MOUSSA MANSOUR, MD, FHRS, FACC

The United States Food and Drug Administration and Prescription Drug Promotion

DOI: 10.19102/icrm.2019.100305

ANKUR S. KALOLA, PharmD¹ and ROBERT DEAN¹

¹Office of Prescription Drug Promotion, United States Food and Drug Administration, Silver Spring, MD, USA

Substrate Mapping and Ablation for Ventricular Tachycardia in Patients with Structural Heart Disease: How to Identify Ventricular Tachycardia Substrate

DOI: 10.19102/icrm.2019.100302

TAKESHI KITAMURA, MD,^1–3,7 CLAIRE A. MARTIN, MD, PhD,^1–4 KONSTANTINOS VLACHOS, MD, PhD,^1–3 RUAIRIDH MARTIN, MD,^1–3,5 ANTONIO FRONTERA, MD, PhD,^1–3,6 MASATERU TAKIGAWA, MD, PhD,^1–3 NATHANIEL THOMPSON, MD,^1–3 GHASSEN CHENITI, MD,^1–3 GREGOIRE MASSOUILLE, MD,^1–3 ANNA LAM, MD,^1–3 FELIX BOURIER, MD,^1–3 JOSSELIN DUCHATEAU, MD,^1–3 THOMAS PAMBRUN, MD,^1–3 ARNAUD DENIS, MD,^1–3 NICOLAS DERVAL, MD,^1–3 MELEZE HOCINI, MD,^1–3 MICHEL HAÏSSAGUERRE, MD, PhD,^1–3 HUBERT COCHET, MD, PhD,^1–3 PIERRE JAÏS, MD, PhD,^1–3 and FRÉDÉRIC SACHER, MD, PhD^1–3

¹IHU Liryc, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac-Bordeaux, France

²Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France

³Centre de recherche Cardio-Thoracique de Bordeaux, University of Bordeaux, Bordeaux, France

⁴Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK

⁵Newcastle University, Newcastle-upon-Tyne, UK

⁶San Raffaele Hospital, Milan, Italy

⁷Tokyo Metropolitan Hiroo Hospital, Tokyo, Japan

Going Beyond Antiarrhythmic–Anticoagulant Drug Interactions: Considerations in the Complex Medicated Patient

DOI: 10.19102/icrm.2019.100301

JAMES A. REIFFEL, MD¹

¹Department of Medicine, Division of Cardiology, Electrophysiology Section, Columbia University, New York, NY, USA

Clinically Important Drug–Drug Interactions Between Antiarrhythmic Drugs and Anticoagulants

DOI: 10.19102/icrm.2019.100304

KAJA M. KONIECZNY, MD¹ and PAUL DORIAN, MD¹

¹Division of Cardiology, Department of Medicine, St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada

Surgical Mapping and Ablation in the Left Ventricular Summit Guided by Presurgery Pericardial Mapping

DOI: 10.19102/icrm.2019.100306

TOSHIMASA OKABE, MD,¹ GREGORY D. RUSHING, MD,² and STEVEN J. KALBFLEISCH, MD, FHRS¹

¹Division of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA

²Division of Cardiothoracic Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA